Serial #79425440 Trademark

Medical devices used for the administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical devices used for the for administration of pharmaceuticals for the treatment of tumours; medical devices used for the for administration of pharmaceuticals for the treatment of carcinoid tumours; medical devices used for the for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical devices used for the administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical devices used for the administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; medical devices used for the administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical devices used for the administration of pharmaceuticals for gastrointestinal bleeding disorders; medical devices used for the administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical devices used for the administration of pharmaceuticals for the treatment of esophageal bleeding; medical devices used for the administration of pharmaceuticals for metabolic disorders; medical devices used for the administration of pharmaceuticals for the treatment of acromegaly; medical devices used for the administration of pharmaceuticals for the treatment of polycystic liver disease; medical devices used for the administration of pharmaceuticals for the treatment of respiratory diseases and syndrome; medical devices used for the administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical devices used for the administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical devices used for the administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical devices used for the administration of pharmaceuticals intended to block growth hormone; medical syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical syringes for administration of pharmaceuticals for the treatment of tumours; medical syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; medical syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic tumours; medical syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; medical syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; medical syringes for administration of pharmaceuticals for the treatment of metabolic disorders; medical syringes for administration of pharmaceuticals for the treatment of acromegaly; medical syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; medical syringes for administration of pharmaceuticals for the treatment of respiratory diseases and syndrome; medical syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical syringes for administration of pharmaceuticals intended to block growth hormone; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of tumours; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens in the nature of microneedle dermal pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for metabolic disorders; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of acromegaly; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens in the nature of microneedle dermal pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens in the nature of microneedle dermal pens for administration of pharmaceuticals intended to block growth hormone; medical devices for subcutaneous administration of pharmaceuticals, namely infusion and injection devices; medical devices for parenteral administration of pharmaceuticals, namely infusion and injection devices; medical devices for injection of pharmaceutical depots, namely, medical fluid injectors; devices for subcutaneous injection of pharmaceutical depot, namely, medical fluid injectors; devices for parenteral injection of pharmaceutical depot; devices for injection of injection fluids; devices for injection of injection depot being pharmaceuticals; medical syringes for subcutaneous administration and injections of pharmaceuticals; medical syringes for parenteral administration and injections of pharmaceuticals; medical syringes for injection of pharmaceutical depots; medical syringes for subcutaneous injection of pharmaceutical depot; medical syringes for parenteral injection of pharmaceutical depot; medical syringes for injections of injection fluids; medical syringes for injection of injection depot; medical syringes for injections; medical syringes for medical uses; pens in the nature of microneedle dermal pens for subcutaneous administration of pharmaceuticals; pens in the nature of microneedle dermal pens for parenteral administration of pharmaceuticals; pens in the nature of microneedle dermal pens for injection of pharmaceutical depots; pens in the nature of microneedle dermal pens for subcutaneous injection of pharmaceutical depot; pens in the nature of microneedle dermal pens for parenteral injection of pharmaceutical depot; pens in the nature of microneedle dermal pens for injection of injection fluids; pens in the nature of microneedle dermal pens for injection of injection depot; pens in the nature of microneedle dermal pens for injections; pens in the nature of microneedle dermal pens for medical uses

Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastroenteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases and syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone